Assignee
NEUROVIVE PHARMACEUTICAL AB
SE·4 granted patents·3 pending applications·2 citations·filing 2012–2017
Top patents by PatentIndex Score
7 records- 0166US10307389B2Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to Complex I-related impairment of mitochondrial oxidative phosphorylationNEUROVIVE PHARMACEUTICAL AB·Filed 2015·Granted Jun 4, 2019·2 cites·4 claims
- 0253US10857150B2Use of sanglifehrin macrocyclic analogues as anticancer compoundsNEUROVIVE PHARMACEUTICAL AB·Filed 2017·Granted Dec 8, 2020·0 cites·2 claims
- 0347US9504728B2Dosage formNEUROVIVE PHARMACEUTICAL AB·Filed 2012·Granted Nov 29, 2016·0 cites·7 claims
- 0437US2019276481A1Liver Prodrugs of Mitochondrial Proton IonophoresNEUROVIVE PHARMACEUTICAL AB·Filed 2017·Application pending·0 cites
- 0536US11147789B2Cell-permeable succinate compoundsNEUROVIVE PHARMACEUTICAL AB·Filed 2015·Granted Oct 19, 2021·0 cites·21 claims
- 0635US2015238563A1Cyclosporine emulsionNEUROVIVE PHARMACEUTICAL AB·Filed 2015·Application pending·0 cites
- 0727US2017105960A1Prodrugs of Succinic Acid for Increasing ATP ProductionNEUROVIVE PHARMACEUTICAL AB·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →